Arcutis Biotherapeutics (ARQT) had the lowest return between December 20, 2022 and November 30, 2023 by a mid-cap US stock, returning -87.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Arcutis Biotherapeutics (ARQT) | 12/20/2022 - 11/30/2023 | -87.49% |
GeneDx (WGS) | 12/20/2022 - 11/30/2023 | -78.79% |
CommScope (COMM) | 12/20/2022 - 11/30/2023 | -76.14% |
Lumen Technologies (LUMN) | 12/20/2022 - 11/30/2023 | -75% |
SolarEdge Technologies (SEDG) | 12/20/2022 - 11/30/2023 | -74.29% |
Nuscale Power (SMR) | 12/20/2022 - 11/30/2023 | -72.16% |
Uniqure (QURE) | 12/20/2022 - 11/30/2023 | -69% |
Plug Power (PLUG) | 12/20/2022 - 11/30/2023 | -68.26% |
Travere Therapeutics (TVTX) | 12/20/2022 - 11/30/2023 | -67.44% |
American Bitcoin (ABTC) | 12/20/2022 - 11/30/2023 | -66.86% |
Enphase Energy (ENPH) | 12/20/2022 - 11/30/2023 | -66.61% |
Regencell Bioscience (RGC) | 12/20/2022 - 11/30/2023 | -63.86% |
Advance Auto Parts (AAP) | 12/20/2022 - 11/30/2023 | -62.96% |
United Natural Foods (UNFI) | 12/20/2022 - 11/30/2023 | -61.42% |
WM Technology (MAPSW) | 12/20/2022 - 11/30/2023 | -60.07% |
Icahn Enterprises (IEP) | 12/20/2022 - 11/30/2023 | -59.33% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 12/20/2022 - 11/30/2023 | -58.38% |
Avidity Biosciences (RNA) | 12/20/2022 - 11/30/2023 | -57.3% |
Akero Therapeutics (AKRO) | 12/20/2022 - 11/30/2023 | -56.94% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 12/20/2022 - 11/30/2023 | -56.73% |
Organon (OGN) | 12/20/2022 - 11/30/2023 | -55.97% |
Sezzle (SEZL) | 12/20/2022 - 11/30/2023 | -55.89% |
Mesoblast (MESO) | 12/20/2022 - 11/30/2023 | -55.84% |
FMC (FMC) | 12/20/2022 - 11/30/2023 | -55.37% |
Hesai Group American Depositary Share, each ADS represents one Class B ordinary share (HSAI) | 12/20/2022 - 11/30/2023 | -55.37% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
